As of June 30, 2026, Central China New Life Ltd. carries a market capitalization of 444.83M, placing it among publicly traded companies globally. Its enterprise value stands at 389.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 444.83M |
| Enterprise Value | 389.27M |
Central China New Life Ltd.'s next confirmed earnings release is scheduled for March 19, 2027.
| Earnings Date | 3/19/2027 |
As of June 30, 2026, Central China New Life Ltd. has 1.29B shares outstanding.
| Shares Outstanding | 1.29B |
These figures are as of June 30, 2026.
| PB Ratio | 0.21 |
| P/TBV Ratio | 0.24 |
As of June 30, 2026, Central China New Life Ltd. maintains a current ratio of 1.49, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.49 |
| Quick Ratio | 0.08 |
| Debt / Equity | 3.14 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 5,089.00 |
As of the close on November 17, 2026, Central China New Life Ltd.'s stock has declined approximately 71.35% over the past 52 weeks. The 50-day moving average sits at 0.25, while the 200-day moving average is 0.36.
| 52-Week Price Change | -71.35% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.36 |
As of June 30, 2026, Central China New Life Ltd. holds 211.84M in cash and equivalents against 70.16M in total debt, resulting in a net debt position of -147.02M. Total book value stands at 2.15B, with working capital of 1.36B providing operational flexibility.
| Cash & Cash Equivalents | 211.84M |
| Total Debt | 70.16M |
| Net Debt | -147.02M |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 1.67 |
| Working Capital | 1.36B |
Already premium?